宋都股份(600077.SH)控股股東解除質押及質押7100萬股
格隆匯1月3日丨宋都股份(600077.SH)公佈,公司於2020年1月3日接到控股股東函告,獲悉宋都控股其所持有公司的7100萬股股份辦理了解除質押及質押業務,佔其所持股份比例的15.13%,佔公司總股本的5.30%。
宋都控股持有公司4.69億股,佔公司總股本比例為35.01%,其持有上市公司股份累計質押數量(含本次)為2.55億股,佔其持股數量比例為54.35%。
宋都控股未來半年內到期的質押股份累計1.84億股,佔其持有公司股份總數的39.22%,佔公司總股本的13.73%,對應的融資餘額2億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.